Dagmar Simon: Influence Statistics

Dagmar Simon

Dagmar Simon

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. | Department of Dermatology, Inselspital, Bern University Hospital, ...

Dagmar Simon: Expert Impact

Concepts for which Dagmar Simon has direct influence: Atopic dermatitis , Eosinophilic esophagitis , Contact allergies , European surveillance , Bullous pemphigoid , Skin diseases , Atopic eczema .

Dagmar Simon: KOL impact

Concepts related to the work of other authors for which for which Dagmar Simon has influence: Atopic dermatitis , Eosinophilic esophagitis , Chronic urticaria , Food allergy , Mast cells , Allergic diseases , Topical corticosteroids .

KOL Resume for Dagmar Simon

Year
2022

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

2021

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Switzerland.

2020

Department of Dermatology and Allergy, University of Berne, Berne, Switzerland

2019

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;

2018

Division of Dermatology and Allergy, Inselspital/University Hospital Bern, Bern, Switzerland

2017

University of Bern Department of Dermatology Bern Switzerland

2016

University Hospital Bern Department of Dermatology Inselspital Bern Switzerland

2015

Department of Dermatology, Inselspital Bern University Hospital Bern Switzerland

2014

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Berne, Switzerland

2013

Inselspital Bern University Hospital University of Bern Department of Dermatology Bern Switzerland

2012

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, CH‐3010 Bern, Switzerland

University Bordeaux Segalen Bordeaux France

2011

Department of Dermatology, University of Bern, Freiburgstrasse Eingang 14 A-D, CH-3010, Bern, Switzerland

2010

Department of Dermatology, University of Bern, Inselspital, 3010 Bern, Switzerland

2009

Department of Dermatology, Inselspital, Bern University Hospital, Bern

2007

Departments of Dermatology (Drs Hassan, D. Simon, Braathen, and Yawalkar) and Pharmacology (Dr H.-U. Simon), University of Bern, Bern, Switzerland.

Department of Dermatology, University of Bern, Bern, Switzerland

Klinik für Dermatologie und Venerologie, Inselspital, Universität Bern, Bern, Schweiz

2006

Department of Dermatology, University of Bern, Bern, Switzerland;

Klinik und Poliklinik für Dermatologie, Inselspital, Universität Bern

2005

Departments of Dermatology

2004

Departments of Dermatology and Pharmacology, Inselspital, University of Bern, 3010 Bern, Switzerland

2003

Departments of, Dermatology and, Pharmacology, University of Bern, Bern, and, Clinic for Dermatology and Allergy (Alexanderhausklinik), Davos, Switzerland

2002

1Department of Dermatology, University of Bern;

2001

Department of Pharmacology, University of Bern, Switzerland;, Division of Environmental Dermatology and Allergy GSF/Technical University of Munich, Germany;, Department of Dermatology, University of Bern, Department of Dermatology, University of Zürich, and, Swiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Davos, Switzerland

1999

Klinik für Dermatologie und Allergie Davos (Direktor: Prof. Dr.Dr. S. Borelli), Davos, XX

Clinic for Dermatology and Allergy (Alexanderhausklinik), Davos, Switzerland

1997

Clinic of Dermatology and Allergy, Alexanderhausklinik, Tobelmuehlestrasse 2, CH‐7270 Davos, Switzerland

1996

Clinic for Dermatology and Allergy, Davos, Switzerland

1995

Swiss Institute of Allergy and Asthma Research (SIAF), and, Klinik fur Dermatologie und Allergie, and, Höhenklinik Valbella, Davos, Switzerland

Prominent publications by Dagmar Simon

KOL-Index: 11132 . BACKGROUND: The diagnosis of atopic dermatitis (AD) is made using evaluated clinical criteria. Management of AD must consider the symptomatic variability of the disease. METHODS: EADV eczema task force developed its guideline for atopic dermatitis diagnosis and treatment based on literature review and repeated consenting group discussions. RESULTS AND DISCUSSION: Basic therapy relies on ...
Known for Atopic Dermatitis | Topical Treatment | Selected Cases | Task Force
KOL-Index: 10672 . BACKGROUND: Contact allergy is a common condition and can severely interfere with daily life or professional activities. Due to changes in exposures, such as introduction of new substances, new products or formulations and regulatory intervention, the spectrum of contact sensitization changes. OBJECTIVE: To evaluate the current spectrum of contact allergy to allergens present in the ...
Known for European Surveillance | Contact Allergies | Baseline Series | Retrospective Analysis
KOL-Index: 9966 . BACKGROUND: Continual surveillance based on patch test results has proved useful for the identification of contact allergy. OBJECTIVES: To provide a current view on the spectrum of contact allergy to important sensitizers across Europe. PATIENTS/METHODS: Clinical and patch test data of 19 793 patients patch tested in 2005/2006 in the 31 participating departments from 10 European countries ...
Known for European Surveillance | Contact Allergies | Atopic Dermatitis | Patch Test
KOL-Index: 9959 . Atopic dermatitis (AD) is a clinically defined, highly pruritic, chronic inflammatory skin disease of children and adults. The diagnosis is made using evaluated clinical criteria. Disease activity is best measured with a composite score assessing both objective signs and subjective symptoms, such as SCORAD. The management of AD must consider the clinical and pathogenic variabilities of the ...
Known for Atopic Dermatitis | Children Adults | Topical Treatment | Position Paper
KOL-Index: 9881 . BACKGROUND: Thymic stromal lymphopoietin (TSLP) that is released by epithelial cells upon certain environmental triggers activates cells of the innate and adaptive immune system resulting in a preferential T helper 2 immune response. By releasing eosinophil extracellular traps (EETs), eosinophils achieve an efficient extracellular bacterial killing. Eosinophil extracellular traps release, ...
Known for Thymic Stromal Lymphopoietin | Extracellular Traps | Eets Eosinophils | Epithelial Cells
KOL-Index: 9529 . BACKGROUND: Analyses of the European Surveillance System on Contact Allergies (ESSCA) database have focused primarily on the prevalence of contact allergies to the European baseline series, both overall and in subgroups of patients. However, affected body sites have hitherto not been addressed. OBJECTIVE: To determine the prevalence of contact allergies for distinct body sites in patients ...
Known for Allergic Contact Dermatitis | Contact Allergies | European Surveillance | Baseline Series
KOL-Index: 9452 . The existing evidence for treatment of atopic eczema (atopic dermatitis, AE) is evaluated using the national standard Appraisal of Guidelines Research and Evaluation. The consensus process consisted of a nominal group process and a DELPHI procedure. Management of AE must consider the individual symptomatic variability of the disease. Basic therapy is focused on hydrating topical treatment, ...
Known for Atopic Dermatitis | Guidelines Treatment | Selected Cases | Disease Exacerbation
KOL-Index: 9392 . A subgroup of patients with atopic dermatitis are known to have normal serum total immunoglobulin E levels, undetectable specific immunoglobulin E, and negative skin prick tests towards allergens. This form of the disease has been termed nonallergic atopic dermatitis. In this study, we found that, among 1151 chronic atopic dermatitis patients, about 10% had normal serum immunoglobulin E ...
Known for Atopic Dermatitis | Skin Cells | Peripheral Blood | Staphylococcal Enterotoxin
KOL-Index: 9248 . BACKGROUND: In several clinical studies, topical calcineurin inhibitors have been shown to be effective in the treatment of atopic dermatitis (AD). They target signaling pathways that control gene expression, particularly the expression of cytokines. OBJECTIVE: We examined the cellular infiltrate in skin lesions of 10 patients with AD and characterized the cytokine pattern expressed by the ...
Known for Atopic Dermatitis | Topical Tacrolimus | Inflammatory Cells | Skin Lesions
KOL-Index: 9186 . BACKGROUND: In the skin, eosinophils are found in a broad spectrum of diseases, including infectious diseases. OBJECTIVE: In this study, we investigated whether eosinophil extracellular traps, structures containing DNA in association with eosinophil granule proteins able to bind and kill bacteria, are present in the skin under various pathologic conditions. METHODS: Immunofluorescence ...
Known for Skin Diseases | Extracellular Dna | Wells Syndrome | Eosinophil Cationic Protein
KOL-Index: 9067 . This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic reviews and published studies into account. This second part of the guideline covers antimicrobial therapy, systemic treatment, allergen-specific ...
Known for Atopic Eczema | European Guidelines | Allergenspecific Immunotherapy | Antipruritic Therapy
KOL-Index: 8786 . BACKGROUND: Hypereosinophilic syndrome (HES) is a heterogeneous group of rare disorders defined by persistent blood eosinophilia > or =1.5 x 10(9)/L, absence of a secondary cause, and evidence of eosinophil-associated pathology. With the exception of a recent multicenter trial of mepolizumab (anti-IL-5 mAb), published therapeutic experience has been restricted to case reports and small ...
Known for Hypereosinophilic Syndrome | Retrospective Analysis | Monoclonal Antibodies | Polyadenylation Factors
KOL-Index: 8766 . BACKGROUND: Atopic eczema (AE) is a chronic inflammatory skin disorder characterized by eczematous skin lesions, pruritus, and typical histopathologic features. OBJECTIVE: We asked whether depletion of B cells by monoclonal anti-CD20 antibody therapy (rituximab) would improve severe AE. METHODS: Six patients (4 women and 2 men) with severe AE received 2 intravenous applications of ...
Known for Atopic Eczema | Monoclonal Antibodies | Cd20 Blymphocytes Dermatitis | Skin Cells
KOL-Index: 8733 . The existing evidence for treatment of atopic eczema (atopic dermatitis, AE) is evaluated using the national standard Appraisal of Guidelines Research and Evaluation. The consensus process consisted of a nominal group process and a DELPHI procedure. Management of AE must consider the individual symptomatic variability of the disease. Basic therapy is focused on hydrating topical treatment, ...
Known for Atopic Dermatitis | Guidelines Treatment | Disease Exacerbation | Topical Corticosteroids
KOL-Index: 8686 . BACKGROUND: Contact allergy to rubber additives is common, particularly in patients with occupational dermatitis. OBJECTIVES: To descriptively analyse and compare patch test reactions in patients patch tested both with the baseline series and with an additional 'rubber series' as used in the department. METHODS: Patch test data from those members of the European Surveillance System on ...
Known for Rubber Series | European Surveillance | Contact Allergies | Patch Test

Key People For Atopic Dermatitis

Top KOLs in the world
#1
Donald Y M Leung
atopic dermatitis eczema herpeticum food allergy
#2
Thomas RM Bieber
atopic dermatitis dendritic cells lupus erythematosus
#3
Jon M Hanifin
atopic dermatitis eczema herpeticum histamine release
#4
Mark Boguniewicz
atopic dermatitis eczema herpeticum tacrolimus ointment
#5
Hywel C G Williams
atopic eczema cochrane skin basal cell carcinoma
#6
Johnannes Ring
atopic eczema west germany histamine release

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. | Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland | Department of Dermatology, Inselspita